Update sobre a Utilidade Clínica das Cirurgias de Glaucoma Minimamente Invasivas (MIGS)

Rossetti L, Digiuni M, Montesano G, Centofanti M, Fea AM, Iester M, et al. Blindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye Clinics. PLoS One. 2015;10:e0136632. doi: 10.1371/journal.pone.0136632.

Miguel A, Silva A, Barbosa-Breda J, Azevedo L, Abdulrah- man A, Hereth E, et al. OCT-angiography detects longitudinal microvascular changes in glaucoma: a systematic review. Br J Ophthalmol. 2022;106:667-75. doi: 10.1136/bjophthalmol-2020-318166.

Ang GS, Eke T. Lifetime visual prognosis for patients with primary open-angle glaucoma. Eye. 2007;21:604-8. doi: 10.1038/ sj.eye.6702284.

Rotchford AP, King AJ. Moving the goal posts definitions of success after glaucoma surgery and their effect on reported outcome. Ophthalmology. 2010;117:18-23 e3. doi: 10.1016/j. ophtha.2009.06.014.

Ahmed, II. MIGS and the FDA: What’s in a Name? Ophthal- mology. 2015;122(9):1737-9.

Malvankar-Mehta MS, Chen YN, Iordanous Y, Wang WW, Costella J, Hutnik CM. iStent as a Solo Procedure for Glaucoma Patients: A Systematic Review and Meta-Analysis. PLoS One. 2015;10:e0128146. doi: 10.1371/journal.pone.0128146.

Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea AM. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. PLoS One. 2017;12:e0183142. doi: 10.1371/journal.pone.0183142.

Ahmed IIK, Rhee DJ, Jones J, Singh IP, Radcliffe N, Gaz- zard G, et al. Three-Year Findings of the HORIZON Trial: A Schlemm Canal Microstent for Pressure Reduction in Primary Open-Angle Glaucoma and Cataract. Ophthalmology. 2021;128:857-65. doi: 10.1016/j.ophtha.2020.11.004.

Ahmed IIK, Fea A, Au L, Ang RE, Harasymowycz P, Jampel HD, et al. A Prospective Randomized Trial Comparing Hydrus and iStent Microinvasive Glaucoma Surgery Implants for Standalone Treatment of Open-Angle Glaucoma: The COMPARE Study. Ophthalmology. 2020;127:52-61. doi: 10.1016/j.ophtha.2019.04.034.

Schlenker MB, Gulamhusein H, Conrad-Hengerer I, Somers A, Lenzhofer M, Stalmans I, et al. Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology. 2017;124:1579-88. doi: 10.1016/j.ophtha.2017.05.004.

Wang B, Leng X, An X, Zhang X, Liu X, Lu X. XEN gel implant with or without phacoemulsification for glaucoma: a systematic review and meta-analysis. Ann Transl Med. 2020;8:1309. doi: 10.21037/atm-20-6354.

Grover DS, Godfrey DG, Smith O, Feuer WJ, Montes de Oca I, Fellman RL. Gonioscopy-assisted transluminal trabeculotomy, ab interno trabeculotomy: technique report and preliminary results. Ophthalmology. 2014;121:855-61. doi: 10.1016/j. ophtha.2013.11.001.

Batlle JF, Corona A, Albuquerque R. Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study. J Glaucoma. 2021;30:281-6. doi: 10.1097/IJG.0000000000001734.

Baker ND, Barnebey HS, Moster MR, Stiles MC, Vold SD, Khatana AK, et al. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study. Ophthalmology. 2021;128:1710-21. doi: 10.1016/j.ophtha.2021.05.023.

Yang SA, Mitchell WG, Hall N, Elze T, Miller JW, Lorch AC, et al. Usage Patterns of Minimally Invasive Glaucoma Surgery (MIGS) Differ by Glaucoma Type: IRIS Registry Analysis 2013-2018. Ophthalmic Epidemiol. 2021;29:443-51. doi: 10.1080/09286586.2021.1955391.